14, 2020 /PRNewswire/ -- Unicycive Therapeutics, Inc., a clinical-stage biotechnology company developing therapies for patients with kidney disease, ...
News
- Unicycive Therapeutics Acquires Renazorb (Lanthanum Dioxycarbonate) from Spectrum ...
- Avelas Receives FDA Breakthrough Therapy Designation for Pegloprastide (AVB-620) for Use ...
SAN DIEGO--(BUSINESS WIRE)--Avelas Biosciences, Inc., pioneering the field of ... San Antonio Breast Cancer Symposium Abstract: 2018. 6. Singer ...
- Pfizer and Moderna could earn $ 32 billion from sales of COVID-19 vaccines
Pfizer's shares are up 12% this year, while those of its partner BioNTech have soared nearly 300%. This brought the value of the German biotech ...
- 'This is our hope and prayer': 28000 COVID-19 vaccines to arrive in SA this week
San Antonio's first week of doses are expected to arrive as soon as Monday ... Several other vaccines are in the works, including one by U.S. biotech ...
- Texas Biomed to test CBD/THC against HIV-induced neurological disorder
San Antonio, Texas (December 11, 2020) - The National Institutes of Health (NIH) awarded Professor Mahesh Mohan, D.V.M., Ph.D., and collaborators ...